07 June 2022

The British Society for Haematology (BSH) has teamed up with the European Hematology Association (EHA) for the first-ever joint Good Practice Paper titled: The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper. 

The British Society for Haematology (BSH) produces Good Practice Papers to recommend good practice in areas where there is a limited evidence base but for which a degree of consensus or uniformity is likely to be beneficial to patient care. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) nomenclature was used to evaluate levels of evidence and to assess the strength of recommendations. The GRADE criteria can be found at http://www.gradeworkinggroup.org.

This Good Practice Paper was produced as a collaboration with the European Hematology Association (EHA) and compiled according to the BSH process. This guideline group included UK-based medical experts representing the BSH and members of the EHA Red Cell and Iron Scientific Working Group (SWG).

Speaking about the collaboration, Professor Michael Laffan, Chair of Haematology Task Force said: "We are delighted to present our guideline on the use of next-generation sequencing in the diagnosis of rare inherited anaemias. This is the first ever guideline to be jointly publish by BSH and EHA teams and is available to read in both BJhaem as well as EHA’s journal HemaSphere."

To view this Good Practice Paper BSH members can click here

Dr Noemi Roy and Dr Roberta Russo present a podcast on the The use of next-generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper which can be found here.